Search Results - "Wan, Shuyan Sabrina"

Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies by Hou, Jue, Zhao, Rachel, Gronsbell, Jessica, Lin, Yucong, Bonzel, Clara-Lea, Zeng, Qingyi, Zhang, Sinian, Beaulieu-Jones, Brett K, Weber, Griffin M, Jemielita, Thomas, Wan, Shuyan Sabrina, Hong, Chuan, Cai, Tianrun, Wen, Jun, Ayakulangara Panickan, Vidul, Liaw, Kai-Li, Liao, Katherine, Cai, Tianxi

“…Although randomized controlled trials (RCTs) are the gold standard for establishing the efficacy and safety of a medical treatment, real-world evidence (RWE)…”
Get full text

Phase 3, randomized, double-blind trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma (RCC): KEYNOTE-564 by Quinn, David I., Zhang, Tian, Gurney, Howard, Doshi, Gurjyot K., Cobb, Patrick Wayne, Parnis, Francis, Lee, Jae-Lyun, Park, Se Hoon, Semenov, Andrey, Chang, Wayne Yen-Hwa, Powles, Thomas, Wan, Shuyan (Sabrina), Poehlein, Christian Heinrich, Choueiri, Toni K.

“…Abstract only TPS712 Background: Most patients with intermediate- to high-risk advanced renal cell carcinoma (RCC) will progress within 3 years following…”
Get full text

Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysis by Li, Kan, Yuan, Shuai Sammy, Wang, William, Wan, Shuyan Sabrina, Ceesay, Paulette, Heyse, Joseph F., Mt-Isa, Shahrul, Luo, Sheng

“…Benefit-risk (BR) assessment is essential to ensure the best decisions are made for a medical product in the clinical development process, regulatory marketing…”
Get full text